8.18 USD
-0.15 (-1.8%)
8.28 USD
+0.1 (+1.22%)
ChartMill assigns a Buy % Consensus number of 80% to VOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.55. This target is 395.66% above the current price.
VOR was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VOR.
In the previous month the buy percentage consensus was at a similar level.
VOR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-15 | Baird | Upgrade | Neutral -> Outperform |
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-30 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-06-27 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-26 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-05-09 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-05-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-03-21 | Stifel | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-13 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-21 | Stifel | Maintains | Buy -> Buy |
| 2024-03-21 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
VOR BIOPHARMA INC / VOR FAQ
What is the price target for VOR stock?
9 analysts have analysed VOR and the average price target is 40.55 USD. This implies a price increase of 395.66% is expected in the next year compared to the current price of 8.18.
What is the consensus rating for VOR BIOPHARMA INC (VOR) stock?
The consensus rating for VOR BIOPHARMA INC (VOR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for VOR stock?
The number of analysts covering VOR BIOPHARMA INC (VOR) is 9.